PHARMA NEWS

TRODELVY® (SACITUZUMAB GOVITECAN)

BJMO - 2025, issue SPECIAL, february 2025

No authors

Read more

Cabozantinib – efficacy and safety across cancer types

BJMO - 2024, issue Special, december 2024

No authors

Read more